Welcome to our dedicated page for Currenc Group news (Ticker: CURR), a resource for investors and traders seeking the latest updates and insights on Currenc Group stock.
Currenc Group Inc. (Nasdaq: CURR) regularly issues news updates that describe its activities as a fintech company focused on artificial intelligence (AI) solutions for financial institutions and digital remittance services. Its press releases cover both operational developments and corporate transactions, providing context for investors and other readers who follow CURR news.
Readers of this news feed can expect coverage of financial results, including quarterly and half-year reports that discuss Total Processing Value (TPV) through Tranglo, remittance revenues, airtime revenues, gross margin and EBITDA. These releases often include management commentary on remittance performance, shifts away from lower-margin airtime transfers and the expansion of AI initiatives.
Currenc’s news also highlights strategic and capital-structure actions. Examples in the supplied disclosures include a proposed reverse merger with Animoca Brands Corporation Limited, a definitive agreement to divest its 60% controlling interest in Tranglo to New Margin Holding Limited, convertible note financings with warrants, and a shares-for-debt transaction in which related party loans were converted into equity. Such announcements describe how the company intends to reshape its business mix, reduce debt and support AI, Web3 and digital assets initiatives.
Additional news items address governance and leadership, such as CEO transitions and amendments to executive employment agreements, as well as steps the company has taken to monitor potential naked short selling in its stock. Together, these categories of news provide insight into how Currenc presents its operational performance, strategic direction and shareholder-related actions over time.
Investors and observers who follow CURR news can use this stream of press releases to track updates on remittance operations, AI product development, proposed corporate combinations and financing arrangements as described directly by the company in its public communications.
Avenir Wellness Solutions (OTCQB: CURR) is set to present at the Planet MicroCap Showcase on April 26, 2023, at 1:30 PM PT (4:30 PM ET). CEO Nancy Duitch will unveil the company's new identity and rebranding strategy, highlighting a high-margin revenue growth plan and ongoing product development. Following a $20 million non-dilutive deal, the company's leadership has focused on enhancing stockholder value through proprietary technology aimed at improving product efficacy and consumer experience. Investors can register to view the presentation virtually. Avenir Wellness is known for its innovative wellness solutions and holds 15 patents for its unique delivery systems. Find further details and updates at www.avenirwellness.com.
Avenir Wellness Solutions, Inc. (OTCQB: CURR) has announced key developments aimed at driving growth in 2023. The company has extended its advertising contract with theSkimm, targeting its audience of over 7 million loyal subscribers to boost sales. The recently launched DNA Complex serum, endorsed by actress Nicole Kidman, has achieved a 77% subscription retention rate, indicating strong consumer approval. In another stride, Avenir has engaged Urish Popeck & Co., LLC as its new independent auditor to enhance financial oversight. Additionally, a new marketing campaign is set to ramp up sales via Amazon and other major retailers, further solidifying the company's market presence. With 15 patents and plans for new product lines, Avenir Wellness is optimistic about significant growth opportunities in the wellness sector throughout the year.
Avenir Wellness Solutions (OTCQB: CURR) announced the launch of its latest skincare innovation, the DNA Complex, under its subsidiary The Sera Labs. This new instant anti-aging serum utilizes Deep Nano Active technology to penetrate the skin deeply, promising immediate wrinkle reduction and long-term effects. The product was celebrated during its debut on the Oscars red carpet, aided by strategic ambassador Nicole Kidman. Retailing at $79.99, DNA Complex aims to redefine skincare with scientifically advanced ingredients that enhance collagen synthesis and skin appearance.
Avenir Wellness Solutions, Inc. (OTCQB:CURR) has announced a partnership with theSkimm social media platform, featuring its brand ambassador Nicole Kidman. The collaboration has resulted in significant month-over-month performance improvements for January 2023, including a 60% increase in online sales and a 2200 rise in social media followers. The company has also launched a new corporate website as part of its rebranding efforts. This initiative aims to enhance shareholder value and promote its innovative wellness technologies.
Avenir Wellness Solutions (OTCQB:CURR) announced the launch of an informational series focused on its unique dual revenue model, highlighting breakthrough consumer wellness products and intellectual property (IP) monetization. In collaboration with New to The Street, the company aims to enhance its visibility through televised content featuring its leadership. CEO Nancy Duitch emphasized the company's innovative delivery technologies and its 15 patents in the wellness sector. This initiative is expected to increase Avenir's market share in a multi-billion-dollar industry, showcasing its commitment to growth and the advancement of its proprietary wellness solutions.
Avenir Wellness Solutions, Inc. (formerly CURE Pharmaceutical Holding Corp.) announced its corporate name change on January 17, 2023, following the sale of certain intellectual property. This rebranding aims to reflect a renewed focus on developing innovative wellness technologies in the beauty sector. The company plans to enhance shareholder value through an incubator strategy, expanding its patent portfolio, and leveraging partnerships with social media influencers. Avenir targets high-margin markets, including the $587.3 billion supplements industry, emphasizing its proprietary delivery systems to improve product efficacy and consumer experience.
CURE Pharmaceutical Holding Corp. (CURR) shares positive developments following its asset sale in July 2022. The company focuses on innovative wellness and beauty products, planning to enhance its market presence through strategic partnerships and influencer marketing, including collaboration with Nicole Kidman. Notable achievements include a 32.1% year-over-year revenue increase in Q3 2022, reaching $1.8 million, with gross margins improving to 80%. With a strong patent portfolio and new products launching in the first half of 2023, CURE is poised for growth in a booming wellness market projected to exceed $450 billion.
CURE Pharmaceutical Holding Corp. (OTCQB:CURR) reported a 32.1% year-over-year revenue increase in Q3 2022, reaching $1.8 million, with expectations of further growth in Q4. Gross margins improved to 80.0%, reflecting effective marketing initiatives. The company reduced SG&A expenses by $0.1 million and narrowed operating losses despite increasing marketing investments. A $20 million asset sale earlier this year enhanced their cash position, supporting future growth in innovative wellness solutions and marketing campaigns.
CURE Pharmaceutical Holding Corp. (OTC: CURR) reported a 31.2% increase in gross revenue, reaching $1.6 million for Q2 2022. The company successfully sold $20 million in assets, bolstering its cash position and reducing debt. SG&A expenses decreased by $3.4 million, while operating loss narrowed by $1.0 million. New marketing programs are yielding positive early results, with sales from the Seratopical skincare line ramping up in Walmart stores. Key appointments to the board enhance governance and strategic direction. CURE aims to accelerate high-margin sales and shareholder value initiatives.
CURE Pharmaceutical has appointed Rob Davidson as Chairman of the Board and Robert J. Costantino to the board, enhancing leadership with extensive financial experience. Davidson, a former CEO, will focus on product development and non-dilutive transactions, while Costantino brings decades of experience from previous leadership roles in financial operations. These changes aim to bolster shareholder value and support ongoing initiatives for growth, especially for the subsidiary The Sera Labs. The company emphasizes continuity and commitment to investors.